Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH website transition announcement about updated terminology and FAQs was removed from the top of the page.SummaryDifference1%

- Check17 days agoChange DetectedThe site footer revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check31 days agoChange DetectedA site-wide notice announces an NIH terminology transition, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record, replacing the previous content. This change hides the trial details and related metadata from the page.SummaryDifference20%

- Check66 days agoChange DetectedThe page now displays a new revision label (v3.7.0) replacing the previous v3.6.6, indicating a software or template update.SummaryDifference0.0%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.